These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1049 related articles for article (PubMed ID: 24328894)

  • 1. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportions and Risk Factors of Developing Multidrug Resistance Among Patients with Tuberculosis in China: A Population-Based Case-Control Study.
    Huai P; Huang X; Cheng J; Zhang C; Wang K; Wang X; Yang L; Deng Z; Ma W
    Microb Drug Resist; 2016 Dec; 22(8):717-726. PubMed ID: 27058017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.
    Mulu W; Mekonnen D; Yimer M; Admassu A; Abera B
    Afr Health Sci; 2015 Jun; 15(2):368-77. PubMed ID: 26124781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study.
    Chen S; Huai P; Wang X; Zhong J; Wang X; Wang K; Wang L; Jiang S; Li J; Peng Y; Ma W
    Int J Infect Dis; 2013 Dec; 17(12):e1116-20. PubMed ID: 23916547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
    Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
    BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
    PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
    Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
    BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and Other Risk Factors for Multi-drug Resistant Tuberculosis in a Mexican Population with Pulmonary Tuberculosis: Case Control Study.
    Gómez-Gómez A; Magaña-Aquino M; López-Meza S; Aranda-Álvarez M; Díaz-Ornelas DE; Hernández-Segura MG; Salazar-Lezama MÁ; Castellanos-Joya M; Noyola DE
    Arch Med Res; 2015 Feb; 46(2):142-8. PubMed ID: 25704633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of drug resistant Mycobacterium tuberculosis among children in China.
    Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD
    Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China.
    Li Q; Zhao G; Wu L; Lu M; Liu W; Wu Y; Wang L; Wang K; Qian HZ; Xie L
    Antimicrob Resist Infect Control; 2018; 7():61. PubMed ID: 29744042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
    Melzer M; Gupta N; Petersen I; Cook S; Hall B
    Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National survey of drug-resistant tuberculosis in China.
    Zhao Y; Xu S; Wang L; Chin DP; Wang S; Jiang G; Xia H; Zhou Y; Li Q; Ou X; Pang Y; Song Y; Zhao B; Zhang H; He G; Guo J; Wang Y
    N Engl J Med; 2012 Jun; 366(23):2161-70. PubMed ID: 22670902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.
    Hanrahan CF; Dorman SE; Erasmus L; Koornhof H; Coetzee G; Golub JE
    PLoS One; 2012; 7(11):e49898. PubMed ID: 23226229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.